Professional Documents
Culture Documents
Gullain Barre Syndrome Final
Gullain Barre Syndrome Final
Syndrome
Presented by: Kate Janelle Cajucom And Angelo Silvestre
Background
• GBS was first described by two French
neurologists, Georges Guillain and Jean Barré,
in 1916.
• It is an autoimmune disorder, where the
immune system mistakenly attacks the myelin
sheath and nerve fibers in the peripheral
nervous system.
• The exact cause of GBS is not well
understood, but it is often triggered by
viral or bacterial infections, such as
respiratory or gastrointestinal infections.
Prevalence
• GBS is considered a rare disease, with an estimated
annual incidence of 1-2 cases per 100,000 people in the
general population.
• It can affect individuals of all ages but is most
common in adults, particularly those in their 30s
and 40s.
Main
Problem
• Can affect the nerves
that control muscle
movement as well as
that transmit pain,
temperature and touch
sensations.
Etiologic
Agent
• Infection with Campylobacteria
jejuni, which causes diarrhea, is
one of the most common
causes of GBS. About 1 in
every 1,000 people with
campylobacteria infection in the
United States gets GBS.
Etiology
● Bacterial infection
● Viral infection
● Protozoan Infection
● Surgeries
● Blood Transfusion
● Transplantation
● anesthesia
● Preceding Heat stroke
● Preceding Vaccination - Swine flu
Incubation
Period
● The three Phases of GBS are
the progressive phase (lasting
from days to 4 weeks), A
plateau phase with little
clinical change (lasting from
days to months), and a
recovery phase.
Mode of
Transmission
● Electromyography. Thin-needle
electrodes are inserted into the
muscles your doctor wants to study.
Collaborative